- Home
- MDGL vs HSIC Comparison
MDGL vs HSIC Comparison
Compare MDGL & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | HSIC |
|---|---|---|
| Founded | 2011 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 9.6B |
| IPO Year | 2005 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MDGL | HSIC |
|---|---|---|
| Price | $435.78 | $81.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $637.92 | $84.50 |
| AVG Volume (30 Days) | 351.2K | ★ 1.4M |
| Earning Date | 05-19-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.32 | 7.21 |
| EPS | N/A | ★ 3.27 |
| Revenue | $180,133,000.00 | ★ $13,201,995,000.00 |
| Revenue This Year | $54.74 | $4.70 |
| Revenue Next Year | $45.72 | $3.77 |
| P/E Ratio | ★ N/A | $24.96 |
| Revenue Growth | N/A | ★ 5.94 |
| 52 Week Low | $265.00 | $60.56 |
| 52 Week High | $615.00 | $89.29 |
Technical Indicators
Market Signals| Indicator | MDGL | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 35.72 | 52.90 |
| Support Level | $410.78 | $74.66 |
| Resistance Level | $452.22 | $82.80 |
| Average True Range (ATR) | 19.50 | 2.60 |
| MACD | -0.81 | 0.14 |
| Stochastic Oscillator | 13.84 | 30.60 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.